Neuronetics Inc (NASDAQ:STIM) currently has a daily average trading volume of 1.70M but it saw 1405124 shares traded in last market. With a market cap of 248.12M USD, the company’s current market price of $3.77 came falling about -7.60 while comparing to the previous closing price of $4.08. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.92 and as low as $0.52. In the recent trading on the day, stock has struck highest price mark of $3.49 while lowest mark touched by it was $4.0385.
Taking a look at 20-day trading activity of Neuronetics Inc (STIM) gives us an average price of $4.17, while its current price level is -36.32% below from 52-week high level whereas it is 625.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.19 while that of 200 days or SMA-200 reads an average of $2.03. A closer look into the stock’s movement over the week reveals that its volatility is standing at 17.24% during that period while stretching the period over a month that decreases to 11.16%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 45.86 which implies that the stock is in neutral territory.
Over the week, STIM’s stock price is moving 4.72% up while it is -18.57% when we observe its performance for the past one month. Year-to-date it is 134.16% up and over the past year, the stock is showing a downside performance of -14.90%.
The company is expected to be releasing its next quarterly report on 2025-Mar-03, for which analysts forecasted an EPS of -0.12 while estimate for next year EPS is -0.3. In next quarter, company is expected to be making quarterly sales of $36.69M as analysts are expecting the sales for current fiscal year at $148.57M and seeing the company making $163.17M in sales next year. Moreover, analysts are in estimates of $29.07M for current-quarter revenue.
Currently, Neuronetics Inc’s total number of outstanding shares is 55.68M with 7.99% of that held by the insiders while 48.99% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -40.93% and return on equity (ROE) at -139.60%. Stock’s beta reads 1.91. Stock has a price to book (P/B) ratio of 7.58 while price to sale or P/S ratio amounts to 3.31. Its return on asset (ROA) is -33.66% on average.
